Evidence map›Paper›PMID 42866779›Full record

ReviewTranslational gastroenterology and hepatology2026

Progress of machine perfusion in managing donor-derived infections in liver transplantation.

Zhihao Wei, Xi Wang, Jiarui Lv, Ying Cheng

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Translational gastroenterology and hepatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhihao WeiDepartment of Organ Transplantation & Hepatobiliary, Key Lab Organ Transplantation of Liaoning Province, The First Affiliated Hospital of China Medical University, Shenyang, China.
Xi WangDepartment of Organ Transplantation & Hepatobiliary, Key Lab Organ Transplantation of Liaoning Province, The First Affiliated Hospital of China Medical University, Shenyang, China.
Jiarui LvDepartment of Organ Transplantation & Hepatobiliary, Key Lab Organ Transplantation of Liaoning Province, The First Affiliated Hospital of China Medical University, Shenyang, China.
Ying ChengDepartment of Organ Transplantation & Hepatobiliary, Key Lab Organ Transplantation of Liaoning Province, The First Affiliated Hospital of China Medical University, Shenyang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Donor-derived infection (DDI), particularly when involving multidrug-resistant organisms (MDROs), represents a formidable barrier in liver transplantation, contributing significantly to high graft discard rates amid the global organ shortage. Conventional static cold storage (SCS) remains inadequate for infected grafts, as it lacks the capacity for dynamic functional assessment or targeted therapeutic intervention, frequently necessitating the exclusion of these high-risk organs. Machine perfusion (MP) has emerged as a transformative strategy, preserving liver grafts under physiological conditions while effectively mitigating ischemia-reperfusion injury (IRI). Beyond its preservation benefits, the integration of antibiotic therapy into MP platforms facilitates a conceptual shift toward active

Indexed as

bacteremiadonor-derived infection (DDI)Liver transplantationmachine perfusion (MP)marginal donor

Identifiers

PMID42866779
PMCPMC13657695

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.